Efficacy of Antibodies and Antiviral Drugs against Omicron BA.2.12.1, BA.4, and BA.5 Subvariants | NEJM

https://www.nejm.org/doi/full/10.1056/NEJMc2207519?query=recirc_mostViewed_railB_article